ES2078671T3 - Compuestos de tiazolidina, su preparacion y su utilizacion terapeutica. - Google Patents

Compuestos de tiazolidina, su preparacion y su utilizacion terapeutica.

Info

Publication number
ES2078671T3
ES2078671T3 ES92311813T ES92311813T ES2078671T3 ES 2078671 T3 ES2078671 T3 ES 2078671T3 ES 92311813 T ES92311813 T ES 92311813T ES 92311813 T ES92311813 T ES 92311813T ES 2078671 T3 ES2078671 T3 ES 2078671T3
Authority
ES
Spain
Prior art keywords
alkyl
hydrogen
preparation
therapeutic use
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92311813T
Other languages
English (en)
Inventor
Takao Yoshioka
Takahide Nishi
Tsutomu Kanai
Yuichi Aizawa
Kunio Wada
Takashi Fujita
Hiroyoshi Horikoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2078671T3 publication Critical patent/ES2078671T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE PRESENTAN COMPUESTOS DE LA FORMULA (I): EN DONDE E1 ES ALQUIL; R2 Y R3 SON CADA UNA ALQUIL O ALCOXIDO, R2 Y R3 JUNTAS FORMAN UN ANILLO DE BENCENO OPCIONALMENTE SUSTITUIDO, Y CUANDO R2 Y R3 JUNTAS FORMAN DICHO ANILLO DE BENCENO, R1 ES HIDROGENO, HALOGENO O ALQUIL; R4 Y R5 SON HIDROGENO, O R4 Y R5 JUNTAS REPRESENTAN UN ANILLO SIMPLE DE CARBONO-CARBONO; Y1 E Y2 SON CADA UNA HIDROGENO, ALQUIL, ACIL, O BENZOIL, NAFTOIL, PIRIDINA-CARBONIL O QUINILINACARBONIL; W ES UN ENLACE SIMPLE O ALQUILENO Y Z ES HIDROGENO O UN CATION. LOS COMPUESTOS TIENEN UNA ACTIVIDAD TERAPEUTICA O PRIFOLACTICA EVALUABLE.
ES92311813T 1991-12-26 1992-12-24 Compuestos de tiazolidina, su preparacion y su utilizacion terapeutica. Expired - Lifetime ES2078671T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34457191 1991-12-26

Publications (1)

Publication Number Publication Date
ES2078671T3 true ES2078671T3 (es) 1995-12-16

Family

ID=18370304

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92311813T Expired - Lifetime ES2078671T3 (es) 1991-12-26 1992-12-24 Compuestos de tiazolidina, su preparacion y su utilizacion terapeutica.

Country Status (21)

Country Link
EP (1) EP0549365B1 (es)
JP (1) JP2833949B2 (es)
CN (1) CN1032751C (es)
AT (1) ATE126221T1 (es)
AU (1) AU654223B2 (es)
CA (1) CA2086277A1 (es)
CZ (1) CZ389792A3 (es)
DE (1) DE69204041T2 (es)
DK (1) DK0549365T3 (es)
ES (1) ES2078671T3 (es)
FI (1) FI925849A (es)
GR (1) GR3017632T3 (es)
HK (1) HK196095A (es)
HU (1) HU215450B (es)
IL (1) IL104238A (es)
MX (1) MX9207595A (es)
NO (1) NO302471B1 (es)
NZ (1) NZ245612A (es)
RU (1) RU2095354C1 (es)
TW (1) TW211007B (es)
ZA (1) ZA9210021B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
EP0783888A1 (en) * 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
US6331633B1 (en) * 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
US6620830B2 (en) 2000-04-21 2003-09-16 Pfizer, Inc. Thyroid receptor ligands
ATE310733T1 (de) * 2000-04-21 2005-12-15 Pfizer Prod Inc Thyroid-rezeptorliganden
EP1276730A2 (en) * 2000-04-24 2003-01-22 ARYx Therapeutics Thiazolidinedione analogues and their use for the treatment of diabetes
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd ５−［６−（２−フルオロベンジルオキシ）−２−ナフチル］メチル−２，４−チアゾリジンジオンの製造方法及びその精製方法
PL2902026T3 (pl) 2006-03-16 2018-03-30 Metabolic Solutions Development Company Llc Analogi tiazolidynodionu do leczenia choroby metabolicznej pośredniczonej przez zapalenie
CA2646149A1 (en) 2006-03-16 2007-09-27 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
AU2008301905B2 (en) * 2007-09-14 2013-06-27 Cirius Therapeutics, Inc. Thiazolidinedione analogues for the treatment of hypertension
RU2564661C2 (ru) 2009-12-15 2015-10-10 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Соли тиазолидиндиона со сниженным сродством к ppar для лечения нарушений обмена веществ
ES2610623T3 (es) * 2010-04-19 2017-04-28 Octeta Therapeutics, Llc Nueva síntesis de compuestos de tiazolidindiona
WO2011133611A1 (en) * 2010-04-21 2011-10-27 Metabolic Solutions Development Company Thiazolidinedione analogues
MX349006B (es) 2010-08-10 2017-07-06 Cirius Therapeutics Inc Nueva sintesis para compuestos de tiazolidindiona.
CN115433144B (zh) * 2022-10-09 2023-09-19 燃点(南京)生物医药科技有限公司 一种脂肪酸酯类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat

Also Published As

Publication number Publication date
JP2833949B2 (ja) 1998-12-09
TW211007B (es) 1993-08-11
GR3017632T3 (en) 1996-01-31
DE69204041D1 (de) 1995-09-14
FI925849A (fi) 1993-06-27
DK0549365T3 (da) 1995-12-18
NO302471B1 (no) 1998-03-09
DE69204041T2 (de) 1996-03-28
FI925849A0 (fi) 1992-12-23
NZ245612A (en) 1994-06-27
NO924964D0 (no) 1992-12-22
CN1032751C (zh) 1996-09-11
ZA9210021B (en) 1993-07-02
CN1074680A (zh) 1993-07-28
ATE126221T1 (de) 1995-08-15
CA2086277A1 (en) 1993-06-27
HU215450B (hu) 1999-04-28
AU3043192A (en) 1993-07-01
JPH05239041A (ja) 1993-09-17
HU9204130D0 (en) 1993-04-28
EP0549365A1 (en) 1993-06-30
RU2095354C1 (ru) 1997-11-10
HUT67788A (en) 1995-04-28
CZ389792A3 (en) 1994-01-19
AU654223B2 (en) 1994-10-27
NO924964L (no) 1993-06-28
IL104238A (en) 1996-10-31
MX9207595A (es) 1994-06-30
HK196095A (en) 1996-01-05
EP0549365B1 (en) 1995-08-09

Similar Documents

Publication Publication Date Title
ES2078671T3 (es) Compuestos de tiazolidina, su preparacion y su utilizacion terapeutica.
ES2115650T3 (es) Derivados de tiazolidina que contienen un grupo quinona, su preparacion y utilizacion en terapeutica.
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
RU92016231A (ru) Тиазолидиновые соединения, способ их получения, фармацевтическая композиция и способ лечения
RU92016230A (ru) Тиазолидиновые соединения, фармацевтическая композиция, способ лечения и способы получения соединений
ATE59844T1 (de) Indolcarboxamidderivate, ihre salze, verfahren und zwischenprodukte, anwendung als heilmittel und zusammensetzungen die sie enthalten.
FI20021652A (fi) Tratsodonin alkyylijohdannaisten valmistuksessa käyttökelpoisia välituotteita
GR3008034T3 (es)
FI943360A (fi) Propoksibentseenijohdannaisia
ES8304998A1 (es) "procedimiento para preparar derivados fenetilados de tiazol".

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 549365

Country of ref document: ES